These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8354118)

  • 21. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance.
    Berho M; Viciana AL; Poppiti RJ; Ruiz P
    J Fla Med Assoc; 1997 Feb; 84(2):104-10. PubMed ID: 9066236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
    Decensi A; Torrisi R; Bruno S; Costantini M; Curotto A; Nicolò G; Malcangi B; Baglietto L; Bruttini GP; Gatteschi B; Rondanina G; Varaldo M; Perloff M; Malone WF; Bruzzi P
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1071-8. PubMed ID: 11045790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects for the use of DNA image cytometry in detection of bladder cancer: a valuable tool?
    Krause FS; Feil G; Bichler KH; Schrott KM; Akcetin ZY
    DNA Cell Biol; 2003 Nov; 22(11):721-5. PubMed ID: 14659044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.
    Puntoni M; Zanardi S; Branchi D; Bruno S; Curotto A; Varaldo M; Bruzzi P; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):979-83. PubMed ID: 17507625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The relationships among DNA ploidy type determined by laser scanning cytometry, the overexpression of p53 protein and the numerical aberrations of chromosome 7 in bladder cancer].
    Kawamura K; Ikeda R; Suzuki K
    Hinyokika Kiyo; 2000 Jun; 46(6):377-83. PubMed ID: 10934605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometry in urologic oncology.
    Stephenson RA; Herr HW
    Urol Clin North Am; 1986 Aug; 13(3):525-30. PubMed ID: 3523929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Flow cytometry in urinary tract malignancies. III. Quantitative analysis of DNA histogram and application to bladder cancer detection, evaluation of the treatment and follow-up examination].
    Matsuura T; Tsujihashi H; Kanda H; Akiyama T; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1985 Jan; 76(1):89-95. PubMed ID: 4010114
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
    Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
    Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometry of urinary bladder washings.
    Klein FA; Melamed MR
    Va Med; 1985 Dec; 112(12):782-5, 789. PubMed ID: 4082754
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
    Krause FS; Feil G; Bichler KH
    Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Options of flow cytometric three-colour DNA measurements to quantitate EGFR in subpopulations of human bladder cancer.
    Brockhoff G; Endl E; Minuth W; Hofstädter F; Knüchel R
    Anal Cell Pathol; 1996 Jun; 11(1):55-70. PubMed ID: 8844105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
    Billerey C; Vieillefond A
    Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular genetic methods in the diagnosis of invasive bladder cancer.
    Krause FS; Feil G; Zumbrägel A; Bichler KH
    Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
    Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
    Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of cytological study by flow cytometry or analysis of image as a complement to macroscopic study by cytoscopy. Apropos of therapeutic follow-up of a case of tumor of the bladder].
    Lizard G; Dusserre-Guion L; Proignot P; Tremeaux JC; Bejui-Thivolet F
    Arch Anat Cytol Pathol; 1993; 41(1):38-44. PubMed ID: 8517763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.
    Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
    Anticancer Res; 1997; 17(4B):2923-6. PubMed ID: 9329565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.